Nature highlights kinase degraders as a potential response to cancer drug resistance
Nature published an article online on 29 September 2026 describing Conery and colleagues’ report of a targeted protein-degrader strategy for kinase-driven cancers. Unlike conventional kinase inhibitors, which block an enzyme’s activity, the approach is…
